-
The Impact of Network Meta-Analyses on HTA Decisions in Oncology: A Review of NICE Appraisals
Sep 9, 2025, 16:22 PM -
Utilization of Real-World Evidence (RWE) in AMNOG Dossiers Following the 2024 GBA Revision of Module 3 Requirements
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Control-IQ Hybrid Closed-Loop System in Adults With Type 1 Diabetes in Sweden
Sep 9, 2025, 16:22 PM -
Use of Encorafenib + Cetuximab EC in Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer (mCRC) in Real-World Settings: Data Visualization From a Pooled Dataset of European Observational Studies
Sep 9, 2025, 16:22 PM -
Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Infective Endocarditis Following FRANCE-TAVI Insights
Sep 9, 2025, 16:22 PM -
Does Insurance Value in Metastatic Breast Cancer Vary by Age Testing for Variation in Willingness to Pay for Novel Treatments Among Women in the US?
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of Epigenetic Drugs in Oncology: A Systematic Review of Economic Evaluations
Sep 9, 2025, 16:22 PM -
Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Sep 9, 2025, 16:22 PM -
Unmet Need and the Public Health Grant: A Data-Driven Tool for Local Authority Spending Decisions
Sep 9, 2025, 16:22 PM -
Inequality in Vaccine Uptake: Lessons Learned From Denmark Analyzing Real-World Data From National Registries
Sep 9, 2025, 16:22 PM -
Addressing the Impact of Alzheimer’s Disease on Care Capacity in the Netherlands: Implications for Health Technology Assessment
Sep 9, 2025, 16:22 PM -
The Clinical Impact of Screening Blood Donations for Hepatitis E Virus in Catalonia
Sep 9, 2025, 16:22 PM -
Rising Polypharmacy Trends and Associated Factors in Chinese Adults With Diabetes: A Population-Based Cohort Study
Sep 9, 2025, 16:22 PM -
Discrete Event Simulation and Treatment Sequencing Cost-Effectiveness Model in Second-Line Highly Active Relapse Remitting Multiple Sclerosis for a NICE Multiple Technology Appraisal
Sep 9, 2025, 16:22 PM -
Healthcare Resource Utilization and Disease Progression in Patients With Primary Hyperoxaluria: A Retrospective Cohort Study
Sep 9, 2025, 16:22 PM -
The Long-Term Cost-Effectiveness of Insulin Icodec vs. Once-Daily Basal Insulin Analogs in Italy
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) in Duchenne Muscular Dystrophy (DMD): Insights From the DMD-QoL Instrument in the United States (US)
Sep 9, 2025, 16:22 PM -
Internal Validation of Type 2 Diabetes and Cardiovascular Events Incidences in the Core Obesity and Diabetes Model
Sep 9, 2025, 16:22 PM -
Health Equity Considerations in Economic Evaluation: Comparative Acceptability and Application Across European HTA Bodies
Sep 9, 2025, 16:22 PM
